Healthcare Industry News:  Perrigo Company 

Biopharmaceuticals Personnel

 News Release - October 31, 2007

Perrigo Elevates Joseph C. Papa to Chairman of the Board

ALLEGAN, Mich., Oct. 31 (HSMN NewsFeed) -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that its Board of Directors appointed President and Chief Executive Officer, Joseph C. Papa, to be Chairman of its Board of Directors. Mr. Papa joined the Company in October of 2006.

Former Perrigo Chairman of the Board of Directors, David T. Gibbons stated, "Joe has done an excellent job during a year of transition for Perrigo. He has demonstrated excellent leadership at both the management and Board levels. His focus on quality, customer service, new products, cost control and continued people development has significantly contributed to our growth this past year. Our entire board looks forward to his leadership." Mr. Gibbons will remain on the Board of Directors.

Mr. Papa added, "On behalf of the Board of Directors, the employees, and the shareholders of Perrigo, I want to thank Dave for his outstanding service as Chairman of the Board of Directors over the past 7 years. During his time as Chairman, President and CEO, he transformed Perrigo into a truly global company and returned over 300% to shareholders. I look forward to his continued counsel."

Gary K. Kunkle, Jr., a director since 2002, continues to serve as lead independent director. Mr. Kunkle is the retired Chairman and Chief Executive Officer of DENTSPLY International, Inc.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended June 30, 2007, as well as the Company's subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Source: Perrigo

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.